OnCore Login

Return to Trial Database

HCRN-LUN00-12

A Randomized, Phase III Trial Comparing CPT-11/ Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated, Extensive Small-Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

Interim Safety Analysis of Irinotecan and Cisplatin Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer
  • A Sandler, C Langer, P Bunn, L Einhorn
A Randomized Phase III Trial Comparing CPT-11 (Irinotecan HCl; Camptosar Injection)/Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated, Extensive, Small-Cell Lung Cancer
  • A Sandler, C Langer, P Bunn, L Einhorn
Randomized Phase II Trial Comparing Irinotecan/Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer
  • N Hanna, P Bunn Jr., C Langer, L Einhorn, T Guthrie Jr., T Beck, R Ansari, P Ellis, M Byrne, M Morrison, S Hariharan, B Wang, A Sandler

Trial Locations

All sites in which the trial HCRN-LUN00-12 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278